πŸ•΅οΈ Recursion Pharmaceuticals, Inc. ($RXRX)

SEC insider & ownership activity, last 12 months Β· CIK 1601830 Β· every row links its SEC filing

Over the last 12 months insiders sold $8.9M with no open-market buying against it. Borgeson Blake sold $4.1M through a 10b5-1 trading plan in 10 lots (Dec–Sep). No red-flag 8-Ks in the window.

🚨 2 signals active β€” planned-vs-executed verdicts, pre-event flags, and cluster context live in the API and the alerts bot.
Oct 2025: net -$1.2M Nov 2025: net -$375K Dec 2025: net -$2.0M Jan 2026: net -$1.3M Feb 2026: net -$1.3M Mar 2026: net -$840K Apr 2026: net -$361K May 2026: net -$364K Jun 2026: net -$368K Jul 2026: net -$158K Aug 2026: net -$98K Sep 2026: net -$179K
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) Β· 5 sellers, $8.9M (36 lots)

InsiderBuysBoughtSellsSoldLast
Borgeson Blake0– 10$4.1MSep 1, 2026
Gibson Christopher0– 17$3.8MJun 5, 2026
Khan Najat0– 4$807KSep 8, 2026
Ben R. Taylor0– 3$158KMar 17, 2026
Bumpus Namandje0– 2$28KJun 18, 2026

5%+ holders

HolderStakeClassScheduleEvent
BlackRock, Inc. 8.5% Class A13GJul 29, 2026 filing β†—
ARK Investment Management LLC 8.5% 13GFeb 14, 2025 filing β†—
ARK Investment Management LLC 7.2% 13GFeb 3, 2026 filing β†—
Catherine D. Wood 7.2% 13GFeb 3, 2026 filing β†—
State Street Corporation 6.6% 13GAug 7, 2026 filing β†—
Vanguard Portfolio Management 6.0% 13GJul 31, 2026 filing β†—
Vanguard Capital Management 5.1% 13GJul 31, 2026 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Najat Khan$79KSep 8, 2026 filing β†—
Borgeson Blake$100KSep 1, 2026 filing β†—
Gibson Christopher$262KAug 21, 2026 filing β†—
Gibson Christopher$255KAug 20, 2026 filing β†—
Gibson Christopher$328KAug 19, 2026 filing β†—
Gibson Christopher$80KAug 18, 2026 filing β†—
Gibson Christopher$331KAug 13, 2026 filing β†—
Gibson Christopher$168KAug 12, 2026 filing β†—
Gibson Christopher$327KAug 10, 2026 filing β†—
Gibson Christopher$325KAug 7, 2026 filing β†—
Borgeson Blake$98KAug 4, 2026 filing β†—
Gibson Christopher$245KAug 4, 2026 filing β†—
Gibson Christopher$225KJul 30, 2026 filing β†—
Gibson Christopher$151KJul 29, 2026 filing β†—
Gibson Christopher$153KJul 27, 2026 filing β†—
Gibson Christopher$304KJul 21, 2026 filing β†—
Gibson Christopher$290KJul 20, 2026 filing β†—
Gibson Christopher$297KJul 17, 2026 filing β†—
Gibson Christopher$311KJul 16, 2026 filing β†—
Gibson Christopher$410KJul 15, 2026 filing β†—
Gibson Christopher$330KJul 14, 2026 filing β†—
Gibson Christopher$343KJul 13, 2026 filing β†—
Gibson Christopher$354KJul 10, 2026 filing β†—
Gibson Christopher$1.1MJul 9, 2026 filing β†—
Gibson Christopher$738KJul 8, 2026 filing β†—
Gibson Christopher$988KJul 7, 2026 filing β†—
Borgeson Blake$158KJul 7, 2026 filing β†—
Gibson Christopher$378KJul 6, 2026 filing β†—
Gibson Christopher$374KJul 2, 2026 filing β†—
Gibson Christopher$367KJul 1, 2026 filing β†—
Gibson Christopher$962KJun 18, 2026 filing β†—
Bumpus Namandje$13KJun 18, 2026 filing β†—
Gibson Christopher$127KJun 18, 2026 filing β†—
Gibson Christopher$145KJun 5, 2026 filing β†—
Najat Khan$84KJun 5, 2026 filing β†—
Bumpus Namandje$16KJun 3, 2026 filing β†—
Borgeson Blake$110KJun 2, 2026 filing β†—
Gibson Christopher$123KMay 22, 2026 filing β†—
Gibson Christopher$135KMay 7, 2026 filing β†—
Borgeson Blake$106KMay 5, 2026 filing β†—
Gibson Christopher$144KApr 22, 2026 filing β†—
Gibson Christopher$124KApr 7, 2026 filing β†—
Borgeson Blake$93KApr 7, 2026 filing β†—
Gibson Christopher$130KMar 23, 2026 filing β†—
Ben R. Taylor$27KMar 17, 2026 filing β†—
Najat Khan$95KMar 9, 2026 filing β†—
Borgeson Blake$588KMar 3, 2026 filing β†—
Gibson Christopher$138KFeb 19, 2026 filing β†—
Ben R. Taylor$41KFeb 18, 2026 filing β†—
Gibson Christopher$165KFeb 4, 2026 filing β†—

Material events (8-K)

ItemEvent date
Earnings (2.02)Aug 5, 2026 filing β†—
Reg FD disclosure (7.01)Aug 5, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 5, 2026 filing β†—
Shareholder vote (5.07)Jun 17, 2026 filing β†—
Earnings (2.02)May 6, 2026 filing β†—
Reg FD disclosure (7.01)May 6, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 6, 2026 filing β†—
Officer/director changes (5.02)Apr 28, 2026 filing β†—
Reg FD disclosure (7.01)Apr 28, 2026 filing β†—
Financial Statements and Exhibits (9.01)Apr 28, 2026 filing β†—
Officer/director changes (5.02)Mar 25, 2026 filing β†—
Reg FD disclosure (7.01)Mar 25, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 25, 2026 filing β†—
Earnings (2.02)Feb 25, 2026 filing β†—
Reg FD disclosure (7.01)Feb 25, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 25, 2026 filing β†—
Reg FD disclosure (7.01)Jan 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jan 12, 2026 filing β†—
Other events (8.01)Dec 8, 2025 filing β†—
Financial Statements and Exhibits (9.01)Dec 8, 2025 filing β†—
Other events (8.01)Nov 26, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 26, 2025 filing β†—
Earnings (2.02)Nov 4, 2025 filing β†—
Officer/director changes (5.02)Nov 4, 2025 filing β†—
Reg FD disclosure (7.01)Nov 4, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 4, 2025 filing β†—
Other events (8.01)Oct 29, 2025 filing β†—